Infiltration of B lymphocytes into the tumor tissue of breast cancer patients is a common occurrence, but the role of these cells in the immune response to the tumor is unknown. Heavy B-cell infiltration in medullary breast carcinoma is well documented and associated with a more favorable prognosis, implying a positive role for the humoral immune response in elimination of tumor cells. Variable B-cell infiltration has also been detected in infiltrating ductal carcinomas of the breast, but little is known about the immunoglobulin gene repertoire of these tumor-infiltrating B lymphocytes and whether they are actively responding to a local stimulus or merely passive bystanders. We have therefore investigated the repertoire of B cells infiltrat...
To investigate immune escape during breast tumor progression, we analyzed the composition of leukocy...
Immune infiltration in solid tumors has emerged as an important aspect of cancer biology. In particu...
We report a case of an invasive ductal breast carcinoma with significant heterogeneity: a HER-2+ tum...
Infiltration of B lymphocytes into the tumor tissue of breast cancer patients is a common occurrence...
Beside other solid tumors, breast carcinomas also have various amounts of tumor- infiltrating T and ...
In breast cancer, humoral immune responses may contribute to clinical outcomes, especially in more i...
Twenty-nine patients with cancer of the breast were examined immunohistopathologically as to the res...
Abstract A hallmark of cancer is a tumor cell’s ability to evade immune destruction. Somatic mutatio...
Burkitt’s lymphoma (BL) is a malignancy of B cells characterized by chromosomal translocations invol...
Primary breast carcinomas are often associated with tumour-infiltrating lymphocytes and metastatic c...
Lymph nodes (LNs) are highly organized secondary lymphoid organs, and reflective of immune responses...
Abstract Background Tumour-infiltrating lymphocytes (TILs) have been demonstrated to significantly i...
Tumors of the splenic marginal zone can present in spleen or blood. The maturational status of the n...
Tumor-infiltrating B cells (TIL-B) in breast cancer (BC) have previously been associated with improv...
Background Accurate assessment of the somatic mutational status of clonal immunoglobulin variable re...
To investigate immune escape during breast tumor progression, we analyzed the composition of leukocy...
Immune infiltration in solid tumors has emerged as an important aspect of cancer biology. In particu...
We report a case of an invasive ductal breast carcinoma with significant heterogeneity: a HER-2+ tum...
Infiltration of B lymphocytes into the tumor tissue of breast cancer patients is a common occurrence...
Beside other solid tumors, breast carcinomas also have various amounts of tumor- infiltrating T and ...
In breast cancer, humoral immune responses may contribute to clinical outcomes, especially in more i...
Twenty-nine patients with cancer of the breast were examined immunohistopathologically as to the res...
Abstract A hallmark of cancer is a tumor cell’s ability to evade immune destruction. Somatic mutatio...
Burkitt’s lymphoma (BL) is a malignancy of B cells characterized by chromosomal translocations invol...
Primary breast carcinomas are often associated with tumour-infiltrating lymphocytes and metastatic c...
Lymph nodes (LNs) are highly organized secondary lymphoid organs, and reflective of immune responses...
Abstract Background Tumour-infiltrating lymphocytes (TILs) have been demonstrated to significantly i...
Tumors of the splenic marginal zone can present in spleen or blood. The maturational status of the n...
Tumor-infiltrating B cells (TIL-B) in breast cancer (BC) have previously been associated with improv...
Background Accurate assessment of the somatic mutational status of clonal immunoglobulin variable re...
To investigate immune escape during breast tumor progression, we analyzed the composition of leukocy...
Immune infiltration in solid tumors has emerged as an important aspect of cancer biology. In particu...
We report a case of an invasive ductal breast carcinoma with significant heterogeneity: a HER-2+ tum...